This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 956146.

Tim Vanuytsel

Consultant Gastroenterologist University Hospitals Leuven, Belgium Assistant Professor of Medicine, KU Leuven, Belgium

(Co-)supervisor of ESRs 3 and 8.

Prof. Dr. Tim Vanuytsel graduated in 2007 from Leuven University Medical School. He obtained a PhD degree in biomedical sciences in 2014 with a thesis on the role and mechanisms of intestinal permeability in functional gastrointestinal disorders. Tim Vanuytsel currently holds a position as a consultant gastroenterologist in Leuven University Hospitals with a clinical focus on functional gastrointestinal disorders and patients with intestinal failure and intestinal transplantation. He is the medical director of the Leuven Intestinal Failure and Transplantation center (LIFT).

Tim Vanuytsel’s research interest lies in the pathophysiology and treatment of functional gastrointestinal disorders, intestinal failure and transplantation and colonic drug disposition (close collaboration with Prof. Patrick Augstijns from the laboratory of Drug Delivery and Disposition at KU Leuven). He has published >100 original research articles and reviews in international peer-reviewed journals on both clinical and basic science aspects of gastroenterology and is the (co-)supervisor of 15 past and present PhD students. He is the deputy editor of Acta Gastroenterologica Belgica, associate editor for Current Opinion in Pharmacology and member of the editorial board of Neurogastroenterology and Motility.

Publications

  • Lemmens, G., Brouwers, J., Snoeys, J., Augustijns, P., Vanuytsel, T. (2020) Insight into the colonic disposition of Sulindac in humans. Journal of Pharmaceutical Sciences, [online] Available at: https://www.sciencedirect.com/science/article/abs/pii/S0022354920305645. DOI: 10.1016/j.xphs.2020.09.034
  • Lemmens, G., Brouwers, J., Snoeys, J., Augustijns, P. and Vanuytsel, T. (2020) Insight into the colonic disposition of celecoxib in humans. European Journal of Pharmaceutical Sciences, 145. DOI: 10.1016/j.ejps.2020.105242
  • Augustijns, P., Vertzoni, M., Reppas, C., Langguth, P., Lennernäs, H., Abrahamsson, B., Hasler, W.L., Baker, J.R., Vanuytsel, T., Tack, J., Corsetti, M., Bermejo, M., Paixão, P., Amidon, G.L. and Hens, B. (2020) Unraveling the behaviour of oral drug products inside the human gastrointestinal tract using the aspiration technique: history, methodology and applications. European Journal of Pharmaceutical Sciences, 155. DOI: 10.1016/j.ejps.2020.105517
  • Vertzoni, M., Augustijns, P., Grimm, M., Koziolek, M., Lemmens, G., Parrott, N., Pentafragka, C., Reppas, C., Rubbens, J., Van Den Abeele, J., Vanuytsel, T., Weitschies, W., and Wilson, C.G. (2019) Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: an UNGAP review. European Journal of Pharmaceutical Sciences, 134. DOI: 10.1016/j.ejps.2019.04.013